This Study Tests a New Medicine Called BI 685509 in Patients That Have Kidney Problems Because of Diabetes. The Study Tests How BI 685509 is Taken up in the Body and How Well it is Tolerated (Multiple Rising Doses)
Public ClinicalTrials.gov record NCT03165227. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomised, Double-blind, Placebo-controlled Trial to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of 3 Multiple Rising Oral Doses of BI 685509 Over 28 Days in Male and Female Patients With Diabetic Nephropathy
Study identification
- NCT ID
- NCT03165227
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Boehringer Ingelheim
- Industry
- Enrollment
- 75 participants
Conditions and interventions
Conditions
Interventions
- BI 685509 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 16, 2017
- Primary completion
- Dec 9, 2019
- Completion
- Dec 9, 2019
- Last update posted
- Jan 12, 2020
2017 – 2019
United States locations
- U.S. sites
- 22
- U.S. states
- 12
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Nephrology Consultants, LLC | Huntsville | Alabama | 35805 | — |
| California Institute of Renal Research | La Mesa | California | 91942 | — |
| Office of Dr. Richard S. Cherlin | Los Gatos | California | 95032 | — |
| Creekside Endocrine Associates, PC | Denver | Colorado | 80246 | — |
| Innovative Research of West Florida, Inc. | Clearwater | Florida | 33756 | — |
| The Center for Diabetes and Endocrine Care | Fort Lauderdale | Florida | 33312 | — |
| Indago Research and Health Center | Hialeah | Florida | 33012 | — |
| South Florida Research Institute | Lauderdale Lakes | Florida | 33313 | — |
| San Marcus Research Clinic, Inc. | Miami | Florida | 33014 | — |
| Ocean Blue Medical Research Center, Inc. | Miami Springs | Florida | 33166 | — |
| Genesis Clinical Research | Tampa | Florida | 33614 | — |
| Boise Kidney and Hypertension Institute | Meridian | Idaho | 83642 | — |
| Research by Design, LLC | Chicago | Illinois | 60643 | — |
| Tulane University Hospital and Clinic | New Orleans | Louisiana | 70112 | — |
| Northwest Louisiana Nephrology L.L.C. | Shreveport | Louisiana | 71101 | — |
| Scott Research, Inc. | Laurelton | New York | 11413 | — |
| PMG Research of Wilmington, LLC | Wilmington | North Carolina | 28401 | — |
| Knoxville Kidney Center PLLC | Knoxville | Tennessee | 37923 | — |
| Research Institute of Dallas | Dallas | Texas | 75231 | — |
| Houston Clinical Research Associates | Houston | Texas | 77090 | — |
| Science Advancing Medicine Clinical Research Center | San Antonio | Texas | 78229 | — |
| York Clinical Research, LLC | Norfolk | Virginia | 23510 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03165227, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 12, 2020 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03165227 live on ClinicalTrials.gov.